In this manuscript, we provide evidence that BCL9 serves as a molecular driver of epithelial mesenchymal transition (EMT) and DCIS invasion by the enhancement of canonical Wnt signaling. The gene discussed is BCL9; the disease is ductal breast carcinoma in situ.